Skip to main content

Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines

Project description

Industry and academia come together to expedite delivery of personalised immunotherapy

Field of science

  • /natural sciences/biological sciences/genetics and heredity/mutation
  • /medical and health sciences/basic medicine/immunology
  • /medical and health sciences/clinical medicine/cancer

Call for proposal

H2020-MSCA-IF-2018
See other projects for this call

Funding Scheme

MSCA-IF-EF-SE - Society and Enterprise panel

Coordinator

PROTEODESIGN SL
Address
Baldiri Reixac 10-12
08028 Barcelona
Spain
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 172 932,48